As hospitals, cognizant of the Diagnostic Related Groupings reimbursement criteria, continue to shorten patients' lengths of stay, home health care is increasingly relied upon to holistically address the needs of patients at home. From a more positive standpoint, health care in the home environment is more comfortable for patients, offers less risk of infection, saves health care dollars, and lends itself to the promotion of ongoing strategies to improve patients' quality of life.
Diabetes mellitus, whether type 1 or type 2, offers special challenges to home health care providers worldwide.
A study funded by the American Diabetes Association (ADA) found that "diabetes is rarely a focus of care for patients with diabetes when they require hospitalization for other conditions." 1 The diagnosis of diabetes may not even be included in the hospital records of people who have diabetes. According to Jeffrey B. Halter, MD, a professor of internal medicine and director of the Geriatric Center at the University of Michigan in Ann Arbor, "Treatment of high blood glucose levels is often ignored in older people or relegated to secondary importance because of perceived barriers that often do not exist." 2 A recent epidemiological study found that 42% of the diabetic population in the United States is 65 years or older. This proportion is projected to increase to 53% by 2025 and to 58% by 2050. 3 That is of concern because people with diabetes and hyperglycemia face a greater risk of major cognitive decline or physical disability than do those without diabetes. In addition, hyperglycemia in the elderly can cause poor sleep, nocturnal falls, incontinence, dehydration, impaired mobility, falls, and visual disturbances that interfere with self administration of insulin. 4 Yet diabetes is often put on the back burner of elderly patient care.
Experts estimate that, in caring for the aging population, home health care providers are an increasingly essential segment of the health care system, especially in the United States.
5-7
Diabetes as a Home Health Care Concern The U.K. Prospective Diabetes Study (UKPDS) 8 and the Diabetes Control and Complications Trial (DCCT) 9 have shown that optimal control of blood glucose can make a difference in preventing diabetes-related complications. The question now is how health care providers can understand and use the UKPDS and DCCT to enhance diabetes management and health status. Rappaport et al. 10 expressed the hope that these studies might encourage patients and providers to take glycemic control seriously "by creating plans to aggressively treat hyperglycemia and other risk factors and recognizing that at any point throughout the life span, patients can alter the appearance or progression of diabetes complications."
Many home health care patients have never achieved glycemic control and are found on admission to home care to have blood glucose levels well over 200 mg/dl, a level considered toxic 11 that impairs leukocyte function, 12 resulting in predisposition to infection. If diabetes is not identified as a home care concern, blood glucose measurement may not even be included in initial or ongoing patient assessments. Again, most home health care patients in the United States are referred by hospitals to home health care for whatever comorbid condition led to their hospitalization; they are rarely referred for diabetes care itself.
Home Health Care: A Definition 13
The term "home health care" encompasses a wide range of health and social services that are usually available 24 hours a day. Home health care is indicated when an individual needs post-hospitalization care or prefers to stay at home but needs ongoing care that cannot easily or effectively be provided by family and friends. Increasingly, older people are choosing to live independent, noninstitutionalized lives. They are receiving home health care services as their physical capabilities decline or as there is a need for high-tech medical treatment (e.g., dialysis) to be carried out in their home environments. In the United States, home health care organizations include: 1. Home health care agencies. These organizations are Medicare-certified and meet minimum federal standards for patient care and management. The services they provide are highly regulated. Home health agencies organize and coordinate the activities of caregiving teams that may include a nurse (the primary provider), a physical therapist, an occupational therapist, a social worker, a registered dietitian (RD), a homemaker (an agency-provided individual who assists with cooking and housekeeping), and home care aides. Home health agencies also 
Home Health Care: Who Pays?
In the United States, Medicare pays for a limited amount of home health care for Medicare recipients who are homebound, under a physician's care, and in need of medically necessary skilled nursing services or therapy programs. Medicaid covers almost unlimited home health care for individuals receiving federally assisted income maintenance payments (e.g., Aid to Families With Dependent Children, Social Security disability income, or the "categorically needy," such as aged, blind, or disabled individuals). Several "Medigap" insurance plans as well as some long-term care insurance plans also cover home care. In countries with cradle-to-grave health care systems, home health care agencies are often able to give free care when there is an assessed and documented need. Individuals without insurance coverage for home care must pay for these services out of pocket.
In the United States, the Center for Medicare and Medicaid Services (CMS, formerly the Health Care Financing Administration) implemented in 2000 a new Prospective Payment System (PPS) and new conditions of participation for home health agencies that have forced home health care agencies to focus on cost containment and quality improvement. Many agencies have had to redesign their methods of care delivery to remain viable. 16 The PPS, implemented in all home care agencies on October 1, 2000, was the greatest change in the Medicare home health care benefit since Medicare was originally enacted in 1965. Its single greatest goal is to maximize effective patient outcomes while minimizing costs and continuing to deliver high-quality patient care. Before the PPS, home care agencies were paid for each patient visit, and supplies needed to care for the patient were reimbursed separately. Now, under the PPS, Medicare gives home health care agencies a standard flat fee to care for and provide necessary supplies for each patient for a 60-day period.
Home care is covered under Medicare Part A. The national standard payment rate for a 60-day episode of home health care is approximately $2,274 and includes services of all disciplines, all nonroutine medical supplies the patient may need during the episode, and any Medicare Part B outpatient therapy costs the patient may incur during that time. For clients with diabetes, home health care agencies must absorb the cost of insulin needles and syringes and blood testing supplies if clinicians are administering or teaching the administration of insulin or performing or teaching blood glucose testing.
The case mix-adjusted rate is calculated using the Home Health Resource Group (HHRG). The HHRG is a point system that combines assigned points for clinical, functional, and service utilization to reflect the intensity and cost of care required by a typical patient with a given group of diagnoses with nursing assessment scores on the 23-item Home Health Care Outcome and Assessment Information Set (OASIS) Questionnaire, which determines resource utilization for different types of patients and measures the intensity of care and services required for each patient. The HHRG score for an individual client is then multiplied by the standardized payment rate for the 60-day episode of home health care (approximately $2,274) to determine the agency's rate of payment for the 60-day episode. Nearly half of all HHRG scores are less than 1, resulting in payments less than the stan-
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Lifestyle and Behavior dardized flat rate. 17 Although CMS recognized that patients/clients with diabetes require greater resource utilization, and therefore a higher reimbursement rate for Home Health Care, there is no question in the OASIS that evaluates the quality of diabetes intervention. The author has published a diabetes assessment tool that CMS could add to the OASIS. 
Diabetes-Related Problems for Home Care 19
In the current health care environment, there will be no administrative movement toward improving quality of diabetes care unless there is a related profit incentive or a care deficitrelated penalty. Evidence-based improved methods and tools for achieving optimal glycemic control are now available. It is ironic that barriers exist simultaneously to prevent the delivery of state-of-the-art diabetes assessment, care, and self-management education to this population of patients in the most cost-effective care-delivery setting: the home. An analysis of the current dilemma follows: 1. There is, at present, no regulatory or accreditation mandate, and thus no incentive, to provide state-ofthe-art diabetes care and education. Although the diagnosis of diabetes results in a higher reimbursement for home health care, there is no regulatory agency that evaluates the quality of home health interventions for patients with diabetes. If diabetes is not the primary diagnosis, documentation of patients' blood glucose level is not required by CMS or any other agency that reviews home care standards. Many home care agencies do not permit nurses to carry blood glucose meters. If patients do not have a blood glucose meter and test strips that are quality controlled with glucose control solution, there is no valid way to assess their glycemic control. Blood glucose testing for patients with diabetes is as important a component of home health care nursing visits as assessment of blood pressure, temperature, weight, heart sounds, and lung sounds. Because home care agencies receive a higher level of reimbursement from CMS for patients with diabetes, the highest quality of intervention for these patients should be expected. Therefore, there should be a mandate from CMS to support the direction for this type of care. Without some regulatory mandate, however, it is unlikely that most U.S. home health care agencies will provide state-of-theart diabetes assessment, care, and education-and especially adequate selfmanagement education-for this greatly at-risk population of patients.
